RVL Pharmaceuticals PLC (RVLPQ)
0.00
USD |
OTCM |
May 31, 16:00
RVL Pharmaceuticals Shareholders Equity (Quarterly): 16.33M for June 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 16.33M |
| March 31, 2023 | 40.00M |
| December 31, 2022 | 51.09M |
| September 30, 2022 | 68.55M |
| June 30, 2022 | 58.51M |
| March 31, 2022 | 69.48M |
| December 31, 2021 | 76.73M |
| September 30, 2021 | 54.75M |
| June 30, 2021 | 68.45M |
| March 31, 2021 | 85.20M |
| December 31, 2020 | 93.86M |
| Date | Value |
|---|---|
| September 30, 2020 | 150.69M |
| June 30, 2020 | 130.91M |
| March 31, 2020 | 143.74M |
| December 31, 2019 | 114.71M |
| September 30, 2019 | 141.70M |
| June 30, 2019 | 257.91M |
| March 31, 2019 | 381.24M |
| December 31, 2018 | 383.85M |
| September 30, 2018 | 415.50M |
| June 30, 2018 | 419.59M |
| December 31, 2017 | 435.78M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
16.33M
Minimum
Jun 2023
257.91M
Maximum
Jun 2019
95.45M
Average
76.73M
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | 1.579M |
| iBio Inc | 24.86M |
| Theriva Biologics Inc | 34.12M |
| Oragenics Inc | 2.625M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 85.40M |
| Total Liabilities (Quarterly) | 69.08M |
| Debt to Equity Ratio | 3.537 |
| Current Ratio | 0.3765 |
| Net Debt Paydown Yield | -4.00% |